Literature DB >> 9631421

Differences in the cerebrovascular anatomy of C57black/6 and SV129 mice.

K Maeda1, R Hata, K A Hossmann.   

Abstract

The vascular architecture of the brain of C57Black/6 and SV129 mice was studied following microvascular injection of carbon black stained latex. The dorsal brain surface was photographed to determine the number, diameter, and position of pial anastomotic vessels between the middle and anterior cerebral arteries. The mean number and diameter of anastomoses were not significantly different, but the line of anastomoses interconnecting the half way points of anastomotic vessels was located significantly closer to the midline in C57Black/6 mice, demonstrating that the middle cerebral artery had a larger vascular supplying territory than in SV129 mice. This explains the larger infarct volume previously reported in C57Black/6 mice, and raises concerns about the use of C57Black/6 and SV129 mice as parent strains for genetically modified animals in stroke research.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9631421     DOI: 10.1097/00001756-199805110-00012

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  37 in total

1.  Transglutaminase 2 protects against ischemic stroke.

Authors:  A J Filiano; J Tucholski; P J Dolan; G Colak; G V W Johnson
Journal:  Neurobiol Dis       Date:  2010-05-06       Impact factor: 5.996

2.  Leptin augments cerebral hemodynamic reserve after three-vessel occlusion: distinct effects on cerebrovascular tone and proliferation in a nonlethal model of hypoperfused rat brain.

Authors:  Hans-Joerg Busch; Stephan H Schirmer; Marco Jost; Sylvia van Stijn; Stephan L M Peters; Jan J Piek; Christoph Bode; Ivo R Buschmann; Guenter Mies
Journal:  J Cereb Blood Flow Metab       Date:  2010-10-27       Impact factor: 6.200

3.  Prostacyclin receptor deletion aggravates hippocampal neuronal loss after bilateral common carotid artery occlusion in mouse.

Authors:  G Wei; K K Kibler; R C Koehler; T Maruyama; S Narumiya; S Doré
Journal:  Neuroscience       Date:  2008-08-20       Impact factor: 3.590

4.  Wide genetic variation in the native pial collateral circulation is a major determinant of variation in severity of stroke.

Authors:  Hua Zhang; Pranay Prabhakar; Robert Sealock; James E Faber
Journal:  J Cereb Blood Flow Metab       Date:  2010-02-03       Impact factor: 6.200

5.  Soluble guanylate cyclase alpha1beta1 limits stroke size and attenuates neurological injury.

Authors:  Dmitriy N Atochin; Izumi Yuzawa; Qian Li; Kristen M Rauwerdink; Rajeev Malhotra; Junlei Chang; Peter Brouckaert; Cenk Ayata; Michael A Moskowitz; Kenneth D Bloch; Paul L Huang; Emmanuel S Buys
Journal:  Stroke       Date:  2010-07-01       Impact factor: 7.914

6.  Intravascular perfusion of carbon black ink allows reliable visualization of cerebral vessels.

Authors:  Mohammad R Hasan; Josephine Herz; Dirk M Hermann; Thorsten R Doeppner
Journal:  J Vis Exp       Date:  2013-01-04       Impact factor: 1.355

7.  Comparison of immunopathology and locomotor recovery in C57BL/6, BUB/BnJ, and NOD-SCID mice after contusion spinal cord injury.

Authors:  Sabina Luchetti; Kevin D Beck; Manuel D Galvan; Richard Silva; Brian J Cummings; Aileen J Anderson
Journal:  J Neurotrauma       Date:  2010-02       Impact factor: 5.269

8.  Rodent models of focal cerebral ischemia: procedural pitfalls and translational problems.

Authors:  Stefan Braeuninger; Christoph Kleinschnitz
Journal:  Exp Transl Stroke Med       Date:  2009-11-25

9.  Outcome of experimental stroke in C57Bl/6 and Sv/129 mice assessed by multimodal ultra-high field MRI.

Authors:  Mirko Pham; Xavier Helluy; Stefan Braeuninger; Peter Jakob; Guido Stoll; Christoph Kleinschnitz; Martin Bendszus
Journal:  Exp Transl Stroke Med       Date:  2010-03-15

10.  Nuclear contrast angiography: a simple method for morphological characterization of cerebral arteries.

Authors:  He Meng; Yezi Peng; Rushdee Hasan; Genggeng Yu; Michael M Wang
Journal:  Brain Res       Date:  2009-01-22       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.